ALNOV.PA
Novacyt S.A.
ParisEUREQUITY
Healthcare
DELAYED
Last price
0.54
▲ 0.05 (9.18%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
0.48
Prev close
0.49
Day high
0.54
Day low
0.48
Volume
750.77K
Market cap
$38.50M
P/E (TTM)
—
52W range
0.29 – 1.04
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
41.67K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 31, 25 | Novacyt SA |
— | 3.01K | — | Direct |
| Mar 31, 25 | Novacyt SA |
— | 14.78K | — | Direct |
| Feb 28, 25 | Novacyt SA |
— | 7.50K | — | Direct |
| Jan 31, 25 | Novacyt SA |
— | 13.94K | — | Direct |
| Nov 30, 24 | Novacyt SA |
— | 2.75K | — | Direct |
| Oct 31, 24 | Novacyt SA |
— | 6.30K | — | Direct |
| Sep 30, 24 | Novacyt SA |
— | 55.57K | — | Direct |
| Aug 31, 24 | Novacyt SA |
— | 32.63K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Novacyt SA |
— | 90.91K | Increase |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+2.51%
+3.9%
1M
+18.53%
+14.8%
3M
-11.65%
-14.7%
6M
+36.50%
+25.4%
YTD
+35.81%
+23.5%
1Y
+14.19%
-5.8%
3Y
-42.75%
-116.9%
5Y
-84.70%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$38.50M
Enterprise value$28.69M
Revenue (TTM)$20.03M
Gross profit$11.52M
EBITDA$2.59M
Net income$-23.45M
EPS (TTM)$-0.39
Free cash flow$7.38M
Total cash$19.27M
Total debt$10.45M
Book value / share$0.39
Shares outstanding72.50M
Float70.41M
Short % of float—
Dividend yield—
Beta (5Y)1.11
Valuation & profitability ratios
Trailing P/E—
Forward P/E2.04
PEG ratio—
Price / sales—
Price / book1.38
EV / revenue1.43
EV / EBITDA11.06
Gross margin57.49%
Operating margin-59.36%
Profit margin-114.25%
Return on equity-65.83%
Return on assets-14.01%
Debt / equity44.71
Current ratio4.75
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $20.03M | $19.63M | $10.62M | $21.04M | +2.0% |
| Operating revenue | $20.03M | $19.63M | $10.62M | $21.04M | +2.0% |
| Cost of revenue | $7.42M | -$12.44M | $7.13M | $15.29M | +159.6% |
| Gross profit | $12.61M | $32.07M | $3.49M | $5.75M | -60.7% |
| Research & development | $4.11M | $2.77M | $2.85M | $5.05M | +48.6% |
| Selling, general & admin | $5.43M | $6.38M | $13.55M | $5.15M | -14.8% |
| Total operating expense | $24.99M | $28.71M | $19.32M | $21.42M | -12.9% |
| Operating income | -$12.38M | $3.37M | -$15.83M | -$15.68M | -467.8% |
| Net interest income | -$111.00K | $545.00K | $985.00K | $918.00K | -120.4% |
| Pre-tax income | -$27.35M | -$39.43M | -$24.46M | -$20.05M | +30.6% |
| Tax provision | -$3.89M | -$732.00K | -$353.00K | $2.15M | -432.0% |
| Net income | -$22.88M | -$41.76M | -$28.29M | -$25.73M | +45.2% |
| Net income to common | -$22.88M | -$41.76M | -$28.29M | -$25.73M | +45.2% |
| Basic EPS | -0.32 | -0.59 | -0.40 | -0.36 | +45.8% |
| Diluted EPS | -0.32 | -0.59 | -0.40 | -0.36 | +45.8% |
| EBIT | -$26.75M | -$38.74M | -$22.03M | -$19.59M | +31.0% |
| EBITDA | -$8.18M | -$31.38M | -$12.38M | -$11.68M | +73.9% |
| Basic shares | 70.63M | 70.63M | 70.63M | 70.63M | 0.0% |
| Diluted shares | 70.63M | 70.63M | 70.63M | 70.63M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $19.15M | $30.45M | $44.05M | $86.97M | -37.1% |
| Cash & short-term investments | $19.16M | $30.46M | $44.06M | $86.98M | -37.1% |
| Accounts receivable | $3.90M | $3.24M | $27.29M | $25.27M | +20.4% |
| Inventory | $2.54M | $2.27M | $3.02M | $3.03M | +11.8% |
| Total current assets | $27.74M | $39.38M | $86.45M | $127.24M | -29.5% |
| Property, plant & equipment | $9.01M | $10.70M | $15.22M | $3.27M | -15.8% |
| Goodwill & intangibles | $3.53M | $20.24M | $31.68M | $9.77M | -82.6% |
| Total assets | $40.33M | $70.63M | $133.81M | $140.90M | -42.9% |
| Total current liabilities | $5.84M | $6.22M | $29.57M | $24.24M | -6.1% |
| Total debt | $10.45M | $11.88M | $13.70M | $872.00K | -12.0% |
| Total liabilities | $16.96M | $22.75M | $46.57M | $25.68M | -25.5% |
| Retained earnings | -$52.94M | -$11.70M | $29.90M | $61.45M | -352.7% |
| Shareholder equity | $23.37M | $47.88M | $87.24M | $115.22M | -51.2% |
| Working capital | $21.90M | $33.16M | $56.88M | $103.00M | -33.9% |
| Net tangible assets | $19.84M | $27.64M | $55.56M | $105.45M | -28.2% |
| Shares issued | 70.75M | 70.70M | 70.68M | 70.64M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$23.45M | -$38.70M | -$24.11M | -$25.73M | — | +39.4% |
| Depreciation & amortisation | $18.56M | -$202.00K | $9.64M | $7.92M | — | +9,290.1% |
| Stock-based compensation | $339.00K | $338.00K | — | — | — | +0.3% |
| Change in working capital | -$639.00K | $31.83M | -$6.36M | -$2.56M | — | -102.0% |
| Operating cash flow | -$9.01M | -$9.15M | -$22.38M | -$13.73M | — | +1.6% |
| Capital expenditure | -$881.00K | -$1.86M | -$671.00K | -$416.00K | — | +52.7% |
| Investing cash flow | -$196.00K | -$1.88M | -$14.03M | -$577.00K | — | +89.5% |
| Share buybacks | -$17.00K | — | -$47.00K | -$13.00K | -$29.00K | — |
| Financing cash flow | -$1.88M | -$1.75M | -$3.09M | -$516.00K | — | -7.4% |
| Free cash flow | -$9.89M | -$11.01M | -$23.05M | -$14.14M | — | +10.2% |
| End cash position | $19.15M | $30.45M | $44.05M | $86.97M | — | -37.1% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2024-12-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $19.15M | $30.45M | -37.1% |
| Cash & short-term investments | $19.16M | $30.46M | -37.1% |
| Accounts receivable | $3.90M | $3.24M | +20.4% |
| Inventory | $2.54M | $2.27M | +11.8% |
| Total current assets | $27.74M | $39.38M | -29.5% |
| Property, plant & equipment | $9.01M | $10.70M | -15.8% |
| Goodwill & intangibles | $3.53M | $20.24M | -82.6% |
| Total assets | $40.33M | $70.63M | -42.9% |
| Total current liabilities | $5.84M | $6.22M | -6.1% |
| Total debt | $10.45M | $11.88M | -12.0% |
| Total liabilities | $16.96M | $22.75M | -25.5% |
| Retained earnings | -$52.94M | -$11.70M | -352.7% |
| Shareholder equity | $23.37M | $47.88M | -51.2% |
| Working capital | $21.90M | $33.16M | -33.9% |
| Net tangible assets | $19.84M | $27.64M | -28.2% |
| Shares issued | 70.75M | 70.70M | +0.1% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $30.52M | +31.7% |
| Next year | — | — | $34.86M | +14.2% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.06%
Held by institutions0.00%
Institutions holding0
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.51
+4.02% from price
SMA 20
0.47
+11.94% from price
SMA 50
0.44
+21.17% from price
SMA 100
0.45
+18.09% from price
SMA 200
0.43
+22.94% from price
EMA 12
0.50
+6.49% from price
EMA 26
0.48
+11.92% from price
EMA 50
0.46
+15.61% from price
RSI (14)
61.4
Neutral
MACD (12,26,9)
0.02
Hist 0.00
ATR (14)
0.03
6.47% of price
Realised vol 30D
67.3%
Annualised
Bollinger upper
0.57
20, 2σ
Bollinger lower
0.38
20, 2σ
50 / 200 cross
Golden
0.44 vs 0.43
Trend bias
Above 200
+22.94%
Risk profile
Beta vs SPY
0.83
Less volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
67.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-57.3%
Peak to trough
Max drawdown 5Y
-93.8%
Peak to trough
ATR 14
0.03
6.47% of price
Beta (reported)
1.11
5Y monthly, from filing
Headlines
Media Advisory - Minister Miller will announce major funding for a cultural organization in Montréal
CNW Group · 13m ago
GE Vernova's Backlog Is Bigger Than Some Countries' GDP. Here's What's Actually Inside the $176 Billion.
Motley Fool · 15m ago
91-year-old supermarket chain closes stores, lays off employees
TheStreet · 23m ago
Stetson Bennett's best plays from 2-TD game vs. Saints Preseason Week 2
NFL Highlights · 29m ago
Emmys: Supporting Actor (Drama) — No One Can Agree on the Frontrunner
Variety · 29m ago
Halliburton (HAL) Brings Three Startups Into Its Labs Push Beyond Oilfield Services
Simply Wall St. · 31m ago
Walmart (WMT) Stock Fair Value Falls After Softer U.S. Comps Prompt Analyst Resets
Simply Wall St. · 31m ago
Mahindra And Mahindra Financial Services (NSEI:M&MFIN) Stock Sees Fair Value Lift On Margin Revisions
Simply Wall St. · 31m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.